ACAP3 Knockout HeLa Cell Line
Cat.No.:
EDC07716
Species:
Human
Cell Name:
HeLa
Gene:
ACAP3
Gene ID:
116983
Size:
1×10⁶cells
ACAP3 Knockout Cell Line (Hela) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07716 |
|---|---|
| Product Name | ACAP3 Knockout Hela Cell Line |
| Cell Line | Hela |
| Cellosaurus ID | CVCL_0030 |
| Cell Line Synonyms | HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
| Gene | ACAP3 |
| NCBI Gene ID | |
| Gene Synonyms | CENTB5 |
| Summary |
Predicted to enable GTPase activator activity and zinc ion binding activity. Predicted to act upstream of or within neuron migration and regulation of neuron projection development. Predicted to be located in endosome membrane and growth cone. [provided by Alliance of Genome Resources, Jul 2025]
|
| Associated Diseases | Cervical Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5, 2days |
| Complete Culture Medium | MEM + 10% FBS |
| Freezing Medium | 70%Complete culture medium+ 20% FBS+ 10% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HeLa | STR Info (Cell bank) Cell Line: HeLa | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 9 | 10 | 9 | 10 |
| D1S1656 | 12 | 15 | 12 | 15 |
| D2S1338 | 17 | 17 | ||
| D3S1358 | 15 | 18 | 15 | 18 |
| D5S818 | 11 | 12 | 11 | 12 |
| D6S1043 | 18 | 18 | ||
| D7S820 | 8 | 12 | 8 | 12 |
| D8S1179 | 12 | 13 | 12 | 13 |
| D12S391 | 20 | 25 | 20 | 25 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 10 | 9 | 10 |
| D18S51 | 16 | 16 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 27 | 28 | 27 | 28 |
| FGA | 18 | 21 | 18 | 21 |
| Penta D | 8 | 15 | 8 | 15 |
| Penta E | 7 | 17 | 7 | 17 |
| TPOX | 8 | 12 | 8 | 12 |
| VWA | 16 | 18 | 16 | 18 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying ACAP3 function, ACAP3 Knockout HeLa Cell Line or ACAP3 overexpression HeLa Cell Line?
The choice depends on the experimental question. ACAP3 (ArfGAP with coiled-coil, ANK repeat and PH domain containing 3) is an Arf6 GTPase-activating protein with characterized roles in neuronal biology. The Knockout line is appropriate for asking whether ACAP3 is required for predicted activities — ACAP3 is an Arf6-specific GAP (GTPase-activating protein) with PH, ArfGAP, and ankyrin repeat domains; ACAP3 has been characterized in neuronal migration and neurite outgrowth through Arf6 regulation. Overexpression is useful for studying ACAP3 in heterologous expression contexts.
For Arf6 signaling research, the EDITGENE ACAP3 Knockout in HeLa provides a clean genetic background for characterizing ACAP3-specific functions. Other ACAP family members (ACAP1, ACAP2) expression analysis aids interpretation. Rescue with wild-type or GAP-dead ACAP3 enables structure-function studies. The knockout is valuable for studying Arf6 GTPase regulation, membrane trafficking, and emerging ACAP3 functions in neuronal biology.
What are the application scenarios for this model?
Primary applications:
• Arf6 GAP activity: Arf6-GTP hydrolysis analysis in ACAP3-null cells.
• Membrane trafficking: Arf6-dependent endocytic recycling and membrane trafficking analysis.
• Neuronal biology: in heterologous neural-relevant contexts, ACAP3's role in neurite outgrowth.
• ACAP family dissection: ACAP1, ACAP2 expression analysis to interpret ACAP3-specific functions.
EDITGENE recommends this model for researchers investigating Arf6 GTPase regulation and membrane trafficking.
Is this ACAP3 Knockout HeLa Cell Line compatible with overexpression rescue experiments?
Yes. ACAP3 rescue experiments require attention to multi-domain architecture:
• Construct design: use a codon-modified ACAP3 sequence with a small C-terminal tag (FLAG, HA). ACAP3 has BAR, PH, ArfGAP, and ankyrin repeat domains — preserve all elements.
• GAP-dead rescue: ArfGAP domain arginine finger mutations abolish Arf6-GAP activity.
• Functional readout: rescue should restore Arf6-GTP hydrolysis and membrane trafficking.
HeLa transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download